Medix Infusion Raises $35M Series B Led by Echo Health Ventures and Acquires Infusion Operations of the Center for Neurology and Spine
January 9, 2023
Medix Infusion closed a $35 million Series B led by Echo Health Ventures with participation from Pittco Direct Investments II and Noro-Moseley Partners, and simultaneously secured a debt facility with Live Oak Bank. Medix will use the capital to support organic growth and to acquire the infusion operations of the Center for Neurology and Spine, expanding its ambulatory infusion footprint into Arizona.
- Buyers
- Medix Infusion, Echo Health Ventures, Pittco Direct Investments II, Noro-Moseley Partners
- Targets
- Infusion operations of the Center for Neurology and Spine
- Sellers
- Center for Neurology and Spine
- Industry
- Healthcare Services
- Location
- Arizona, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Vivo Infusion Acquires Specialty Infusion
June 20, 2023
Healthcare Services
Vivo Infusion, a national provider of community-based ambulatory infusion and injection care, has acquired Specialty Infusion, a provider of ambulatory infusion and specialty pharmacy services operating 14 centers across New York, Massachusetts, and New Jersey. The deal expands Vivo's footprint to a combined 55 ambulatory infusion centers across ten states; financial terms were not disclosed.
-
IVX Health Acquires Precision Healthcare
October 14, 2020
Healthcare Services
IVX Health acquired Precision Healthcare, a Nashville-based operator of 12 ambulatory infusion centers in Tennessee and northern Arkansas. The acquisition was financed with preferred equity led by Linden Capital Partners and joined by McKesson Ventures, Health Velocity Capital, and Nueterra Capital; Precision was previously a subsidiary of BAI Healthcare Services (a portfolio company of EW Healthcare Partners).
-
BioVie Acquires Biopharma Assets of NeurMedix
June 11, 2021
Pharmaceuticals
BioVie Inc. acquired the biopharmaceutical assets of privately held NeurMedix, including NE3107, an orally administered small-molecule inhibitor targeting neuroinflammation and insulin resistance. The deal paid NeurMedix shareholders newly issued BioVie shares and cash at closing, with additional contingent cash and equity payments tied to clinical and regulatory milestones; the acquisition expands BioVie's pipeline into neurodegenerative diseases and oncology.
-
Great Hill Partners Invests $100M in IVX Health
September 21, 2021
Healthcare Services
Great Hill Partners completed a $100 million Series F minority growth investment in IVX Health to fund the outpatient infusion provider's expansion into new markets. The capital will be used to accelerate market entry and broaden IVX Health's network of infusion and injection centers across the United States.
-
Rubicon Founders Acquires Majority Stake in Horizon Infusions
February 7, 2025
Healthcare Services
Rubicon Founders has made a majority investment in Horizon Infusions, Ohio’s largest network of ambulatory infusion centers, with BroadOak Capital remaining as a minority investor. The investment will support Horizon’s growth from its 21 centers in Ohio and enable expansion into new markets while preserving the company’s patient-centered, outpatient infusion model.
-
BioMatrix Infusion Pharmacy Acquires LUX Infusion
October 17, 2025
Healthcare Services
BioMatrix Infusion Pharmacy acquired LUX Infusion, an Alaska-based ambulatory infusion center operator, adding three infusion centers effective October 17, 2025. The deal expands BioMatrix's national ambulatory infusion footprint and integrates LUX's clinical teams and operating model to accelerate growth and extend home infusion nursing into the Pacific Northwest.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.